Quantification of the hepatocyte lipid-droplet accumulation (Fig. 5D) showed a significantly lower percent area of liver lipid droplets in HFD–smad2-βKO mice than the HFD controls, indicating that the loss of smad2 improves hepatic steatosis in the HFD mice. The gene discussed is SMAD2; the disease is fatty liver disease.